About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT05415969

CKD-aP Among Adults on Dialysis in Switzerland

Chronic Kidney Disease Associated Pruritus (CKD-aP) represents a localized or a generalized skin itch, which is a common symptom occurring in end-stage renal disease and dialysis. The prevalence of CK...

Lead sponsor: University of Applied Sciences of Western Switzerland•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Applied Sciences of Western Switzerland

Collaborators

University of Lausanne Hospitals
Hôpital Fribourgeois
University Hospital, Geneva
Valais Hospital
eHnv Hospital
Rennaz Hospital
Intercantonal Hospital of Broye
GHOL Nyon Hospital
Dialyse Riviera
Cecil Clinic Hirslanden Private Hospital Group
Vifor Pharma
Réseau Hospitalier Neuchâtelois

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adult ≥ 18 years old
•Diagnosed with end-stage renal disease and receiving hemodialysis for at least 6 months
•Able to communicate in French or availability of a French-speaking close relative for translation
•Signed informed consent
•Reporting moderate to severe CKD-aP for the participant considered as a case
•Reporting no or mild CKD-aP for the participant considered as a control Cases and controls will be matched by age-group, sex, and dialysis modality (hemodialysis or peritoneal dialysis).

Exclusion Criteria

•Presence of cognitive impairment or cognitive disorder

Related studies

Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.

NCT06474169 · Chronic Kidney Diseases

Efficacy of pHA130 Hemoadsorption on Protein-Bound Uremic Toxins and Quality of Life in Kidney Failure

NCT07656168 · ESRD (End-Stage Renal Disease), Maintenance Hemodialysis

Access to Kidney Transplant of Obese Patients Beginning Dialysis

NCT04748770 · Kidney Transplant Access, Obese Patients, and more

PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

NCT06422871 · End Stage Renal Disease, Hemodialysis Access Failure

Pulsatile Flushing Technique in Reducing Blockage of T-CVAD for Haemodialysis Patients

NCT07567456 · Haemodialysis Patients, Blockage of Tunnelled Central Venous Access Device, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 18, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment401

Start dateSep 2022

Last updatedNov 18, 2023

Condition

Chronic Kidney Diseases Dialysis Chronic Kidney Diseases Associated Pruritus

Locations shown

University of Lausanne Hospitals

Lausanne, Canton of Vaud

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 18, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions